UroGen Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
URGN Key Statistics
Stock Snapshot
As of today, UroGen Pharma(URGN) shares are valued at $48.12. The company's market cap stands at 2.99B, with a P/E ratio of -24.13.
As of 2026-08-14, UroGen Pharma(URGN) stock has fluctuated between $47.67 and $49.60. The current price stands at $48.12, placing the stock +0.9% above today's low and -3.0% off the high.
UroGen Pharma(URGN) shares are trading with a volume of 859.71K, against a daily average of 1.12M.
During the past year, UroGen Pharma(URGN) stock moved between $15.86 at its lowest and $49.67 at its peak.
During the past year, UroGen Pharma(URGN) stock moved between $15.86 at its lowest and $49.67 at its peak.
URGN News
UroGen Pharma’s recently reported Q2 2026 results showed sales rising to US$72.46 million from US$24.22 million a year earlier, while net loss narrowed to US$14...
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.